Biotech Goes Mobile

If you thought BlackBerry (Nasdaq:BBRY) was a dead mobile device provider, think again.

They’re currently forging a partnership with NantHealth, a healthcare focused data provider, which falls underneath Patrick Soon-Shiong’s state of the art cancer fighting conglomerate, NantWorks.

What makes BlackBerry such an attractive partner for the healthcare and biotech business is their unparalleled security. While Apple and Samsung may have the most user-friendly devices on the market, BlackBerry has built their products around protection and security, which is why it’s so heavily embraced by an industry that’s highly regulated for protecting your private health information.

NantHealth and BlackBerry have developed a secure cancer genome browser that gives doctors the ability to access a patient’s genetic data on the BlackBerry Passport smartphone.

The company has stated that this capability enables deep, interactive reporting on genomics data for physicians, gives oncologists a tool to view individual genetic alterations in a disease and allows them to highlight relevant treatment options.

The browser application is fully encrypted which will allow physicians to receive and securely analyze the data wherever they are.   This is a large game-changer from the traditional analysis practice that required physicians to physically go to the hospital or a secure data facility to perform their analysis work.

Dr. Patrick Soon-Shiong, the billionaire who founded NantWorks & NantHealth, stated: “Our partnership with BlackBerry has really been able to create a scalable super-computer in the palm of the hands of the doctor.”

The rollout of this capability will occur at the Consumer Electronics Show (CES) in Las Vegas later this month. The professional healthcare community will be able to purchase BlackBerry Passport devices with the secure browser program in early 2015.

BlackBerry does have plans to roll out the secure application on rival devices and operating systems. They plan to accomplish this by making the application continue to connect and operate through the secure BlackBerry network.

Dr. Soon-Shiong continues to push the envelope with his healthcare-based technology conglomerate NantWorks. He’s currently collaborating with BlackBerry on what will revolutionize the transport of big data sets for healthcare.

I currently track trends surrounding health care and biotech utilizing my social media collective intelligence system and provide alerts in my Biotech Intel Trader service.

As always, I will continue to monitor the market’s social media collective intelligence and keep you updated on the latest trends.

Image Signature

 

 

 

 

Ben

 

Categories: Biotech

About Author

Ben Benoy is a veteran of the U.S. Marine Corps and has been an active retail trader since 2006. He identifies investment opportunities based on key social media trends. He first identified the concept in 2008 and has since developed a tool for tracking investment “chatter” between social media users. His proprietary Social Media Stock Sentiment system has developed into a state-of-the-art platform that identifies and classifies chatter about stocks through algorithms and other indicators to forecast stock-price direction. Ben’s track record speaks for itself — over the past 12 months, his system boasts a win rate of 82.2% on 112 stock trades.